Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

Arthritis and Rheumatism

Volumn 48, Issue 4, 2003, Pages 963-970

  Ekström, Karin ^a   Hjalgrim, Henrik ^b   Brandt, Lena ^a   Baecklund, Eva ^c   Klareskog, Lars ^a   Ekbom, Anders ^a   Askling, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GENETIC RISK; HODGKIN DISEASE; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; REGISTER; RELATIVE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 0037386804     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10939     Document Type: Article

References (44)

1. Felson D. Epidemiology of the rheumatic diseases. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 3-11.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
3. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-23.
4. Linet MS, Pottern LM. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res 1992;52 Suppl:5468-73s.
5. Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985;78:29-32.
6. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
7. Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994;120:35-9.
8. Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997;8:201-4.
9. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A:1753-7.
10. Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88:497-502.
11. Blornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:66-71.
12. Askling J, Ekbom A. Risk of non-Hodgkin's lymphoma following tuberculosis. Br J Cancer 2001;84:113-5.
13. Vineis P, Crosignani P, Sacerdote C, Fontana A, Masala G, Miligi L, et al. Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health 2000;54:431-6.
14. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002;287:1413-9.
15. Go MF, Smoot DT. Helicobacter pylori, gastric MALT lymphoma, and adenocarcinoma of the stomach. Semin Gastrointest Dis 2000;11:134-41.
16. Mellemkjaer L, Alexander F, Olsen JH. Cancer among children of parents with autoimmune diseases. Br J Cancer 2000;82:1353-7.
17. Linet MS, McLaughlin JK, Harlow SD, Fraumeni JF. Family history of autoimmune disorders and cancer in multiple myeloma. Int J Epidemiol 1988;17:512-3.
18. Woods WG, Robison LL, Kim Y, Schuman LM, Heisel M, Smithson A, et al. Association of maternal autoimmunity with childhood acute lymphocytic leukemia (ALL): a case/control study [abstract]. Proc Am Assoc Cancer Res 1987;28:251.
19. Till M, Rapson N, Smith PG. Family studies in acute leukaemia in childhood: a possible association with autoimmune disease. Br J Cancer 1979;40:62-71.
20. Conley CL, Misiti J, Laster AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore) 1980;59:323-34.
21. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999;5:119-33.
22. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 1999;117:1433-7.
23. Swedish Hospital Discharge Register 1987-1996, quality and contents. Stockholm: Swedish National Board of Health and Welfare, Centre for Epidemiology; 1998.
24. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 1980;2:1-59.
25. The Multi-Generation Register. Orebro, Sweden: Statistics Sweden; 2001. Report no. 2001:5.
26. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
27. Causes of Death 1997. Stockholm: National Board of Health and Welfare; 2000.
28. Breslow NE, Day NE. The design and analysis of cohort studies. Oxford: Oxford University Press; 1987.
29. Tennis P, Andrews E, Bombardier C, Wang Y, Strand L, West R, et al. Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada. J Clin Epidemiol 1993;46:685-95.
30. Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev 2000;9:59-64.
31. Katusic S, Beard CM, Kurland LT, Weis JW, Bergstralh E. Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med 1985;78:50-5.
32. Prior P, Symmons DP, Hawkins CF, Scott DL, Brown R. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 1984;43:128-31.
33. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
34. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 2001;27:750-6.
35. Simonsson M, Bergman S, Jacobsson LT, Petersson IF, Svensson B. The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 1999;28:340-3.
36. Allebeck P, Ljungstrom K, Allander E. Rheumatoid arthritis in a medical information system: how valid is the diagnosis? Scand J Soc Med 1983;11:27-32.
37. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: eleven-year follow-up of an epidemiological study. Scand J Rheumatol 1981;10:301-6.
38. Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol 2002;29:906-12.
39. Wen WQ, Shu XO, Sellers T, Bhatia S, Lampkin B, Robison LL. Family history of cancer and autoimmune disease and risk of leukemia in infancy: a report from the Children's Cancer Group (United States and Canada). Cancer Causes Control 1998;9:161-71.
40. Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998;92:3018-24.
41. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 1994;54:497-505.
42. Taylor GM, Dearden S, Payne N, Ayres M, Gokhale DA, Birch JM, et al. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer 1998;78:561-5.
43. Deodhar SD. Autoimmune diseases: overview and current concepts of pathogenesis. Clin Biochem 1992;25:181-5.
44. Shirai T. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL). Tohoku J Exp Med 1994;173:133-40.